Trial Profile
A Retrospective Study To Evaluate The Current Utilization Of Desvenlafaxine Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Desvenlafaxine (Primary) ; Adrenergic uptake inhibitors; Serotonin uptake inhibitors
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Oct 2010 New trial record